Product information and disease descriptionPlace of product in therapyDisease description
Clinical presentation - signs and symptoms
9 evidence topics · 10 sources
Neuroglycopenic symptoms: insulinoma
“neuroglycopenic symptoms such as confusion, visual disturbances, or seizures may also occur. The latter may cause patients to be misdiagnosed with a psychiatric or neurological disorder.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“96% of the patients had neuroglycopenic symptoms, and 77% had autonomic symptoms.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The most common presenting symptoms were confusion (86%), drowsiness (58%), and excessive sweating (57%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“All patients had neuroglycopenic symptoms including confusion (83%) and personality change or bizarre behavior (64%).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Amnesia for hypoglycemia was common (41%).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Timing of symptoms: fasting and postprandial hypoglycemia in insulinoma
“Symptoms occur mainly in the fasting state, but up to 20% of patients also described postprandial symptoms” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Hypoglycemia was reported solely in the fasting state in 73%, the fasting and postprandial state in 21%, and exclusively postprandially in 6%.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Tumor-related features: aggressive insulinoma
“Aggressive insulinomas are characterized by rapid onset of symptoms, larger size, and expression of ARX and alpha-1-antitrypsin, and decreased or absent immunohistochemical expression of insulin, PDX1, and GLP-1R.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Adrenergic, cholinergic, and neuroglycopenic symptoms: tumor hyperinsulinism
“The clinical manifestations of hypoglycemia are marked by adrenergic, cholinergic, and neuroglycopenic symptoms such as tremors, diaphoresis, confusion, seizures, and loss of consciousness, and may lead to life-threatening consequences” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Neuroglycopenic symptoms: NICTH
“Loss of consciousness and confusion were the most common features in the patients, present in 26.7% and 21%, respectively.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Weight loss, dizziness and weakness were other relatively less common features.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In paraneoplastic hypoglycemia, the symptoms predominantly manifest as neuroglycopenic, affecting cognitive function and mental status significantly.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“On the other hand, in cases of recurrent or gradual-onset hypoglycemia, autonomic symptoms like sweating and tremors may be less noticeable.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Tumor-related symptoms and order of presentation: NICTH
“Hypoglycemic attack was the onset of disease in 31 of 65 cases (48%), but the tumor was revealed prior to the occurrence of hypoglycemia in 34 cases (52%).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Hypoglycaemia was identified as the presenting feature of NICT in 42% (98) of patients.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Symptoms directly related to the tumor typically include weight loss, abdominal mass, pain, dyspnea, or incidental findings during routine examinations” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In a minority of patients, the tumors (hepatomas, fibromas, and fibrosarcomas are the most common among many) release into the circulation enough IGF-2-related peptides to mimic the fasting hypoglycemia characteristic of patients with insulin-producing islet-cell tumors.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote